Key result
Transcatheter aortic valve implantation demonstrated pooled survival rates of 69.0% at 2 years and 61.4% at 3 years in patients unfit for surgery.
Why the study?
What are the early and intermediate survival rates after transcatheter aortic valve implantation in high-risk patients unfit for surgery?
Meta-Analysis (n=3,500)
What are the early and intermediate survival rates after transcatheter aortic valve implantation in high-risk patients unfit for surgery?
TAVI demonstrates favorable intermediate survival rates (69.0% at 2 years, 61.4% at 3 years) in high-risk patients, supporting its use as a valid alternative to surgical valve replacement for patients unfit for surgery.
No takes yet. Share an insight, caveat, or question.
Supports TAVI in surgery-ineligible patients; extends pooled intermediate survival estimates.
Messori et al. (2013) conducted a meta-analysis in Patients unfit for surgical aortic valve replacement (n=3,500). Transcatheter aortic valve implantation (TAVI) was evaluated on Survival at 2 years. Transcatheter aortic valve implantation demonstrated pooled survival rates of 69.0% at 2 years and 61.4% at 3 years in patients unfit for surgery.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: